DICER1 and cancer: The estimated prevalence of pathogenic DICER1 variants in the general population is ~1:10,600, and approximately 30,000 Americans harbor pathogenic DICER1 mutations12,14; however, this prevalence is seemingly higher and is estimated at ~1:4600 in the adult cancer population14.